Jessica Silva-Fisher, PhD

Research Program Solid Tumor Therapeutics
Jessica Silva-Fisher

Researcher Background

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Section of Stem Cell Biology, WashU Medicine

Training

  • 2014 - 2019: Postdoctoral fellow, genomic incRNA cancer biology, Washington University, St. Louis, MO

Education

  • 2011: PhD, Biomedical Sciences, Mayo Clinic College of Medicine and Science, Rochester, MN

Research & Selected Publications

Research Interest

Characterizing and evaluating how RNAs can regulate the genome in aggressive forms of cancer including multiple myeloma, breast cancer and colon cancer

Research Publications

Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis.
Authors:

Mishra R, Thunuguntla P, Duraiyan D, one or more additional authors omitted Silva-Fisher J

Journal & Year:

Oncogenesis • 2025

LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.
Authors:

Mishra R, Thunuguntla P, Perkin A, one or more additional authors omitted Silva-Fisher J

Journal & Year:

Res Sq • 2024

LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.
Authors:

Mishra R, Thunuguntla P, Perkin A, one or more additional authors omitted Silva-Fisher J

Journal & Year:

bioRxiv • 2024